Rolfo C, Hess LM, Jen MH, Peterson P, Li X, Liu H, Lai Y, Sugihara T, Kiiskinen U, Vickers A, Summers Y. External control cohorts for the single-arm LIBRETTO-001 trial of selpercatinib in RET+ non-small-cell lung cancer. ESMO Open. 2022 Aug;7(4):100551. doi: 10.1016/j.esmoop.2022.100551
Nadal N, De Batlle J, Barbe F, Marsal JR, Sanchez-de-la-Torre A, Tarraubella N, Lavega M, Sanchez-de-la-Torre M. Predictors of CPAP compliance in different clinical settings: primary care versus sleep unit. Sleep Breath. 2018 Mar;22(1):157-63. doi: 10.1007/s11325-017-1549-7
Davis KL, Kaye JA, Masters ET, Iyer S. Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinib. Curr Oncol. 2018 Feb;25(1):e40-9. doi: 10.3747/co.25.3723